Back to Search
Start Over
Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer
- Source :
- Gut, 55, 1781-8, Gut, 55(12), 1781-1788. BMJ PUBLISHING GROUP, Gut, 55, 12, pp. 1781-8
- Publication Year :
- 2006
-
Abstract
- Contains fulltext : 51354.pdf (Publisher’s version ) (Closed access) BACKGROUND: Patients with early-onset colorectal cancer (CRC) or those with multiple tumours associated with hereditary non-polyposis colorectal cancer (HNPCC) raise suspicion of the presence of germline DNA mismatch repair (MMR) gene mutations. AIM: To analyse the value of family history, microsatellite instability (MSI) analysis and MMR protein staining in the tumour to predict the presence of an MMR gene mutation in such patients. METHODS: In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification. MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours. RESULTS: 25 pathogenic mutations (8 in MLH1, 9 in MSH2 and 8 in MSH6) were found. MSI analysis missed three and immunohistochemistry (IHC) missed two mutation carriers. Sensitivities of family history, MSI analysis and IHC for the presence of a mutation were 76%, 82% and 88%, specificities were 64%, 70% and 84%, and positive predictive values were 19%, 23% and 38%, respectively. Multivariate analysis showed the highest odds ratio for IHC (38.3, 95% confidence interval 9.0 to 184). Prevalence of pathogenic germline MMR gene mutations in patients with CRC before the age of 50 years was 6% and in those with > or =2 HNPCC-associated tumours was 22%. In the second group, no mutation carriers were found among the 29 patients who were diagnosed with their first tumour after the age of 60 years. CONCLUSION: Family history, MSI analysis and IHC are indicative parameters to select patients with CRC for MMR gene mutation analysis. The data show that IHC is the best single selection criterion.
- Subjects :
- Oncology
Male
Pathology
Base Pair Mismatch
MICROSATELLITE INSTABILITY
DNA Mutational Analysis
Gene mutation
DNA Mismatch Repair
Neoplasms, Multiple Primary
GENOMIC DELETIONS
Molecular diagnosis, prognosis and monitoring [UMCN 1.2]
Cancer
REVISED BETHESDA GUIDELINES
Gastroenterology
Nuclear Proteins
CLINICAL-CRITERIA
DNA, Neoplasm
GERMLINE MUTATIONS
Middle Aged
CARRIERS
Lynch syndrome
Neoplasm Proteins
DNA-Binding Proteins
MutS Homolog 2 Protein
Growth and differentiation [NCMLS 3]
Female
Colorectal Neoplasms
MutL Protein Homolog 1
Adult
medicine.medical_specialty
Heterozygote
congenital, hereditary, and neonatal diseases and abnormalities
Adolescent
Biology
MLH1
LYNCH-SYNDROME
Genomic disorders and inherited multi-system disorders [IGMD 3]
Germline mutation
Translational research [ONCOL 3]
Predictive Value of Tests
Internal medicine
medicine
HMSH2 GENE
Humans
IMMUNOHISTOCHEMISTRY
neoplasms
Germ-Line Mutation
Adaptor Proteins, Signal Transducing
Aged
Family Health
Hereditary cancer and cancer-related syndromes [ONCOL 1]
Microsatellite instability
nutritional and metabolic diseases
medicine.disease
Colorectal Neoplasms, Hereditary Nonpolyposis
digestive system diseases
MSH2
MSH6
Carrier Proteins
Subjects
Details
- Language :
- English
- ISSN :
- 00175749
- Volume :
- 55
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Gut
- Accession number :
- edsair.doi.dedup.....ee848a21c011b16acb6994a03e8b6679
- Full Text :
- https://doi.org/10.1136/gut.2005.090159